/ CBET Updates

From Pharma To Biopharma — Education & Workforce Training Programs Converge To Meet Industry Needs

June 9, 2021

In 1982, when the FDA approved the first recombinant drug (insulin), there was a clear line between pharmaceutical companies and, as they were called at the time, biotechnology companies. That line has faded into history, with the convergence of the biopharmaceutical industry.

https://www.bioprocessonline.com/doc/from-pharma-to-biopharma-education-workforce-training-programs-converge-to-meet-industry-needs-0001